Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
75-87-6
Molecular formula
C2HCl3O
Molecular weight
147.39 g/mol
Drug class
Chloral hydrate sedative-hypnoticcentral nervous system depressant
Mechanism of action
Metabolised to trichloroethanol, which enhances GABAA-mediated inhibitory neurotransmission and produces sedation and hypnosis. It also has a narrow therapeutic margin and significant respiratory, cardiac and gastrointestinal toxicity.
Indications / reported uses
Historically used for short-term sedation and insomnia and for procedural sedation in selected paediatric settings; use is now restricted or discouraged in many jurisdictions because of safety concerns and availability of safer alternatives
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Chloral PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Chloral Permitted Daily Exposure (PDE) report (the Chloral PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Chloral Occupational Exposure Limit (OEL) report (the Chloral OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.